Failure of combination therapy with S-carbamyl-L-cysteine (SCC; NSC-102498) and L-asparaginase (NSC-109229) for L-asparaginase-resistant mouse lymphoma.
Prager
M D
MD
Department of Surgery, University of Texas Southwestern Medical School, Dallas, USA.
Rothberg
L
L
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000008:administration & dosage*; D045744:Cell Line, Tumor; D002470:Cell Survival; D003545:Cysteine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D019008:Drug Resistance, Neoplasm; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D008954:Models, Biological; D008956:Models, Chemical; D009368:Neoplasm Transplantation; D016896:Treatment Outcome
C006894:S-carbamylcysteine; D001215:Asparaginase; D003545:Cysteine